Ehrsson H - Search Results

1

An expanded CAG repeat sequence in spinocerebellar ataxia type 7.

Lindblad K, Savontaus ML, Stevanin G, Holmberg M, Digre K, Zander C, Ehrsson H, David G, Benomar A, Nikoskelainen E, Trottier Y, Holmgren G, Ptacek LJ, Anttinen A, Brice A, Schalling M. Lindblad K, et al. Among authors: ehrsson h. Genome Res. 1996 Oct;6(10):965-71. doi: 10.1101/gr.6.10.965. Genome Res. 1996. PMID: 8908515 Free article.

2

Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.

Hansson J, Edgren M, Ehrsson H, Ringborg U, Nilsson B. Hansson J, et al. Among authors: ehrsson h. Cancer Res. 1988 Jan 1;48(1):19-26. Cancer Res. 1988. PMID: 3334994

3

Oxaliplatin degradation in the presence of chloride: identification and cytotoxicity of the monochloro monooxalato complex.

Jerremalm E, Hedeland M, Wallin I, Bondesson U, Ehrsson H. Jerremalm E, et al. Among authors: ehrsson h. Pharm Res. 2004 May;21(5):891-4. doi: 10.1023/b:pham.0000026444.67883.83. Pharm Res. 2004. PMID: 15180350

4

D-Methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics.

Ekborn A, Laurell G, Johnström P, Wallin I, Eksborg S, Ehrsson H. Ekborn A, et al. Among authors: ehrsson h. Hear Res. 2002 Mar;165(1-2):53-61. doi: 10.1016/s0378-5955(02)00277-0. Hear Res. 2002. PMID: 12031515

5

Intracochlear administration of thiourea protects against cisplatin-induced outer hair cell loss in the guinea pig.

Ekborn A, Laurell G, Ehrsson H, Miller J. Ekborn A, et al. Among authors: ehrsson h. Hear Res. 2003 Jul;181(1-2):109-15. doi: 10.1016/s0378-5955(03)00181-3. Hear Res. 2003. PMID: 12855369

6

Increased toxicity and DNA cross-linking by peptide bound m-L-sarcolysin (Peptichemio) as compared to melphalan and m-L-sarcolysin in human melanoma cell lines.

Lewensohn R, Ehrsson H, Hansson J, Ringborg U. Lewensohn R, et al. Among authors: ehrsson h. Anticancer Res. 1991 Jan-Feb;11(1):321-4. Anticancer Res. 1991. PMID: 2018366

7

Cisplatin-induced hearing loss: influence of the mode of drug administration in the guinea pig.

Ekborn A, Laurell G, Andersson A, Wallin I, Eksborg S, Ehrsson H. Ekborn A, et al. Among authors: ehrsson h. Hear Res. 2000 Feb;140(1-2):38-44. doi: 10.1016/s0378-5955(99)00190-2. Hear Res. 2000. PMID: 10675634

8

Stability of cisplatin and its monohydrated complex in blood, plasma and ultrafiltrate--implications for quantitative analysis.

Andersson A, Ehrsson H. Andersson A, et al. Among authors: ehrsson h. J Pharm Biomed Anal. 1995 Apr;13(4-5):639-44. doi: 10.1016/0731-7085(95)01292-s. J Pharm Biomed Anal. 1995. PMID: 9696580

9

Aspects concerning busulfan pharmacokinetics and bioavailability.

Hassan M, Ehrsson H, Ljungman P. Hassan M, et al. Among authors: ehrsson h. Leuk Lymphoma. 1996 Aug;22(5-6):395-407. doi: 10.3109/10428199609054777. Leuk Lymphoma. 1996. PMID: 8882952 Review.

10

Distribution of cisplatin in perilymph and cerebrospinal fluid after intravenous administration in the guinea pig.

Laurell G, Andersson A, Engström B, Ehrsson H. Laurell G, et al. Among authors: ehrsson h. Cancer Chemother Pharmacol. 1995;36(1):83-6. doi: 10.1007/BF00685738. Cancer Chemother Pharmacol. 1995. PMID: 7720182

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters